Author: Ying Wen; Lan Wei; Yuan Li; Xiujuan Tang; Shuo Feng; Kathy Leung; Xiaoliang Wu; Xiong-Fei Pan; Cong Chen; Junjie Xia; Xuan Zou; Tiejian Feng; Shujiang Mei
Title: Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China Document date: 2020_3_23
ID: ddq2q1pg_33
Snippet: Although our study had major strengths such as population-wide case identification in a major migrant city, a large sample size, and complete profiling of epidemics along the timeline of population interventions, there were several limitations that should be acknowledged. First, since some patients were still under treatment so far, we could not yet report the complete data of the disease progression on severity or assess predictors of clinical o.....
Document: Although our study had major strengths such as population-wide case identification in a major migrant city, a large sample size, and complete profiling of epidemics along the timeline of population interventions, there were several limitations that should be acknowledged. First, since some patients were still under treatment so far, we could not yet report the complete data of the disease progression on severity or assess predictors of clinical outcomes. Second, important information, such as timelines of possible exposure, illness onset, and medical visits, was self-reported in the epidemiological investigations, which might be subject to recall bias. Third, we did not have enough information on comorbid conditions, . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- case identification and cc ND international license: 1, 2
- case identification and disease progression: 1, 2, 3
- case identification and epidemiological investigation: 1, 2
- case identification and illness onset: 1, 2, 3, 4
- case identification and important information: 1, 2
- case identification and international license: 1, 2, 3
- case identification and large sample size: 1
- cc ND international license and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8
- cc ND international license and clinical outcome predictor: 1
- cc ND international license and disease progression: 1, 2, 3, 4, 5, 6, 7, 8
- cc ND international license and epidemiological investigation: 1
- cc ND international license and illness onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cc ND international license and important information: 1
- cc ND international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc ND international license and large sample size: 1, 2
- clinical outcome and illness onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- clinical outcome and important information: 1, 2
- clinical outcome and international license: 1, 2, 3, 4, 5, 6, 7, 8
- clinical outcome and large sample size: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date